KGA-2727
KGA-2727 is a potent, selective SGLT1 inhibitor with high selectivity over SGLT2. It is a research tool for studying glucose absorption mechanisms in diabetes, applicable in both in vitro binding assays and in vivo metabolic studies.
Product Specifications
CAS Number
666842-36-0
Product Name Alternative
Antidiabetic, orally, inhibit, KGA 2727, KGA2727, KGA-2727, glucose, hyperglycemia, human SGLT1, first, Inhibitor, insulin, rat SGLT1, SGLT1, SGLT, Sodium-dependent glucose cotransporters
Field of Research
Pharmacology & Drug Discovery
Purity
98.46% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (9.32 mM) ; DMSO:100 mg/mL (186.35 mM)
Smiles
CC (C) c1[nH]nc (O[C@@H]2O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@H]2O) c1Cc1ccc (OCCCNCCC (N) =O) cc1C
Molecular Formula
C26H40N4O8
Molecular Weight
536.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2080704-01 0.1 mL
FITC-Linked Polyclonal Antibody to Glutaminase (GLS)
Sign In for Pricing
View Details MBS2080704-02 0.2 mL
FITC-Linked Polyclonal Antibody to Glutaminase (GLS)
Sign In for Pricing
View Details MBS2080704-03 0.5 mL
FITC-Linked Polyclonal Antibody to Glutaminase (GLS)
Sign In for Pricing
View Details